Dr Sabine Luik

Chief Medical Officer

Sabine Luik

Sabine Luik, MD, MBA has been our Chief Medical Officer (CMO) since 2018. She reports directly to the Chief Scientific Officer.

Throughout her time with GSK, her leadership has ensured our regulatory, quality, safety, medical affairs and value evidence and outcomes teams, as well as development groups in China and Japan, work together to successfully achieve our ambitions for patients.

The organisation of the CMO, including Global Regulatory, Safety & Quality, is responsible for benefit-risk decision making for pipeline and marketed medicines and vaccines, Safety and Pharmacovigilance, Epidemiology, Bioethics, Medical Governance, Regulatory Policy, Quality and risk management (including data governance).

Across her organisation, her teams are driven by delivering what matters better and faster, always in the right way, for patients around the world.

Follow Sabine on LinkedIn

Success in medicine development is directly tied to applying diverse views to problem solving. At GSK we constantly work to ensure clinical trial participants are representative of the patient populations affected by the diseases we aim to treat. Trials that reflect the true diversity of the population impacted by a disease – for example a women’s health issue – will lead to better insights in the development of a medicine and how it is prescribed for patients.

Sabine's achievements

2018 – Present

Lupus Science Image

Chief Medical Officer (CMO) for GSK. Since September 2023, the CMO reports directly to our Chief Scientific Officer.

2015 – 2018

GSK Hepatitis B science image

Member of the Health Section Governing Board for BIO

2013 – 2018

HIV Science Image

Membership in senior committees/activity in Efpia/PhRMA

2012 – Present

Member of the International Council on Harmonisation (ICH) Management Committee on behalf of EFPIA

1998 – 2018

Tuberculosis cell

Held senior positions in Medical, Regulatory and Pharmacovigilance with Boehringer Ingelheim where she established a global epidemiology team and worked across multiple therapeutic areas.


Immuno Oncology science image

Received her MD from Johannes Gutenberg University (JGU), Mainz, Germany, and her Executive MBA from JGU in cooperation with the McCombs School of Business, University of Texas, Austin. She is a licensed physician in Germany.